AWM
GILD icon

Austin Wealth Management’s Gilead Sciences GILD Stock Holding History

Austin Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$249K Sell
1,854
-5
-0.3% -$659 0.05% 113
2026
Q1 		$261K Sell
1,859
-155
-8% -$21.7K 0.06% 106
2025
Q4 		$243K Buy
2,014
+42
+2% +$5.1K 0.04% 151
2025
Q3 		$240K Sell
1,972
-56
-3% -$6.37K 0.04% 140
2025
Q2 		$228K Buy
2,028
+35
+2% +$3.73K 0.04% 128
2025
Q1 		$212K Buy
+1,993
New +$206K 0.04% 125

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Austin Wealth Management's GILD Position: Q2 2026 in Review

Austin Wealth Management reduced its Gilead Sciences (GILD) stake by 0.27% in Q2 2026, selling an estimated $659 and leaving 1,854 shares worth $249K. The position accounts for 0.05% of the portfolio, ranked #113.

Austin Wealth Management first reported a position in GILD in Q1 2025 and has held it in 6 quarters since. The position peaked at $261K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Austin Wealth Management held 1,854 shares of Gilead Sciences worth $249K as of Q2 2026.
  • Austin Wealth Management sold 5 Gilead Sciences shares in Q2 2026, an estimated $659.
  • Gilead Sciences made up 0.05% of Austin Wealth Management's portfolio in Q2 2026, its #113 holding.
  • Austin Wealth Management first reported a position in Gilead Sciences in Q1 2025 and has held it in 6 quarters since.
  • Austin Wealth Management's Gilead Sciences position peaked at $261K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Austin Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.